entertainment -WSS

entertainment

author：knowledge 2025-10-01 04:12:35 - browse：352

The Chamber of Commerce in downtown Washington, DC. — The U.S. Chamber of Commerce sued to stop a new Medicare drug price negotiation program from going into effect. Adobe

WASHINGTON — Attorneys for the U.S. Chamber of Commerce and the federal government sparred Friday over whether drugmakers have enough say in Medicare’s new drug price negotiation program, in the first oral arguments in a lawsuit challenging the new law.

The two sides debated two questions: whether the Chamber of Commerce would be sufficiently injured by the law to file a lawsuit, and whether the negotiation program was a violation of drugmakers’ due process rights.

The hearing was held in the U.S. District Court for the Southern District of Ohio, and Judge Michael Newman, a Trump nominee, presided. Newman didn’t ask any questions of the attorneys, so the hearing didn’t provide any hints about which way he might be leaning on the issues.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Advances in CAR

WSS

Covid hospitalizations on the rise, Humana says

Fight over Supreme Court dialysis ruling puts kidney patients at risk

NIH nominee Bertagnolli will get October confirmation hearing

An outdated Medicare rule harms dementia patients with anxiety

Elevance PBM president out as customers face prescription chaos

For pregnant people, addiction treatment shouldn't mean a call to child protective services

hotspot

entertainment

entertainment

Affirmative action in medical school literally saved lives

Elevance PBM president out as customers face prescription chaos

Trump demands the U.S. pay no more for drugs than other countries … again

AstraZeneca chief proposes a novel edit to the drug pricing bill

Heart attack and stroke risk calculators need revising

Medicaid rebukes states for mistakenly disenrolling children

23andMe had bad news about my health. I wish a person had delivered it

ASCO Takeaways: Winners, snoozers, and the art of cancer care

ChatGPT in medicine: STAT answers readers' burning questions

What American doctors can learn from their Israeli counterparts

explore

FDA approves Moderna’s RSV vaccine, its second licensed product

What American doctors can learn from their Israeli counterparts

Crinetics acromegaly drug succeeds in late

Structure Therapeutics oral GLP

UnitedHealth CEO's Medicaid comments send insurer stocks diving

The most pressing bird flu mysteries scientists want answered

focus

explore

Wikipedia

knowledge